Capecitabine suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy

dc.authorid0000-0002-2448-2337
dc.contributor.authorBora, Ejder Saylav
dc.contributor.authorTastaynatan, Halil
dc.contributor.authorErdogan, Mumin Alper
dc.contributor.authorAtasoy, Ozum
dc.contributor.authorErbas, Oytun
dc.date.accessioned2025-05-10T19:31:23Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractAim: Capecitabine was developed as a pro-drug of 5-FU. Epilepsy is a common and often debilitating neurological disease that is characterized by recurrent spontaneous seizures arising from abnormal electrical activity in the brain. The mechanism of the excitatory properties of folates is uncertain, but there is some evidence that they may act by blocking or reversing GABA-mediated inhibition. Material and Methods: In this study, we investigated the potential anti-folate effects of capecitabine by administering doses of 250 mg/kg IP and 500 mg/kg IP. Results: We show that capecitabine statistically suppresses seizure activity in EEG telemetry in the brain, prolongs the time to the first myoclonic jolt, and reduces Racine's convulsion score, suppresses folate level and therefore significantly reduces PTZ-induced seizures. Discussion: It can be assumed that the anti-tumoral mechanism and anti-epileptic mechanism are largely due to the anti-Folate effect in the brain.
dc.identifier.doi10.4328/ACAM.20407
dc.identifier.endpage170
dc.identifier.issn2667-663X
dc.identifier.scopusqualityN/A
dc.identifier.startpage166
dc.identifier.urihttps://doi.org/10.4328/ACAM.20407
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7925
dc.identifier.volume12
dc.identifier.wosWOS:000731632100008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBayrakol Medical Publisher
dc.relation.ispartofAnnals of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectCapecitabine
dc.subjectCancer therapy
dc.subjectEpilepsy
dc.subjectFolat level
dc.subjectBrain
dc.titleCapecitabine suppresses seizure activity in rats with pentylenetetrazol-induced epilepsy
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
7925.pdf
Boyut:
169.17 KB
Biçim:
Adobe Portable Document Format